Opiate and Cocaine Exposed Newborns: Growth

This investigation examined growth parameters at birth in 204 infants born to mothers who used cocaine and/or opiates during pregnancy.  Analyses considered both type (cocaine, opiate or both) and pattern of in utero drug exposure.  A unique feature of the investigation was the large group of opiate exposed infants.  Singleton newborn infants born to cocaine and/or opiate using mothers, were recruited.  Using a structured interview and urine toxicology screens, information was obtained on the type and pattern of in utero drug exposure for each infant.  Outcome measures included birth weight, length, and head circumference.  Birth weight and length were significantly different by type of drug exposure with the opiate only infants the largest (p=.0001) and longest (p=.008).  Differences in head circumference size were not statistically significant (p=.58).  Mean Z-scores were I S.D. lower for birth weight and length and 1.5 S.D. lower for head circumference when compared to National Center for Health Statistics (NCHS) growth standards.  This study provides support that in utero cocaine exposure may confer more risk for somatic growth retardation at birth than opiate exposure even when controlling for nicotine and alcohol exposure, amount of prenatal care, gender, maternal age, education and marital status.

(Source: Butz et al.  “Opiate and Cocaine Exposed Newborns: Growth Outcomes”, ‘Child & Adolescent Sub. Abuse’, 1-16, 1999)

Back to top of page

Powered by WordPress